Specific nuclear proteins interact with the rous sarcoma virus internal enhancer and share a common element with the enhancer located in the long terminal repeat of the virus

Larry M Karnitz, Steven Faber, Roger Chalkley

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We have documented that the Rous sarcoma virus (RSV) internal enhancer functions in the nontransformed Baby Hamster Kidney (BHK) cell line. The sequences within this region were assayed for their ability to bind to specific factors present in BHK nuclear extracts using the gel retardation assay and DNAse I footprinting. At least two sequences within the internal enhancer which can specifically bind nuclear factors in vitro have been identified. These regions are located between nucleotides 813-850 and 856-877. These sites map within the overall region of the internal enhancer which has been shown to be essential for enhancer activity and within the specific region which can function as an orientation independent enhancer. Using the DNase I footprinting and binding data to design an oligonucleotide, we have demonstrated that an oligonucleotide extending from nucleotides 804-877 will substitute efficiently as an enhancer. We also demonstrate that the SV40 enhancer does not compete for the factors which bind to the RSV internal enhancer, whereas an oligonucleotide to the binding site for EFII in the LTR can compete for factor binding to the internal enhancer.

Original languageEnglish (US)
Pages (from-to)9841-9859
Number of pages19
JournalNucleic Acids Research
Volume15
Issue number23
DOIs
StatePublished - Dec 10 1987
Externally publishedYes

Fingerprint

Rous sarcoma virus
Terminal Repeat Sequences
Oligonucleotides
Nuclear Proteins
Viruses
Virus
Nucleotides
Protein
Internal
Cricetinae
Kidney
Deoxyribonuclease I
Electrophoretic Mobility Shift Assay
Binding sites
Assays
Gels
Binding Sites
Cells
Cell Line
Substitute

ASJC Scopus subject areas

  • Genetics
  • Statistics, Probability and Uncertainty
  • Health, Toxicology and Mutagenesis
  • Applied Mathematics
  • Genetics(clinical)
  • Toxicology

Cite this

@article{ecf9fb89e2ff4617a29f0804adc088ea,
title = "Specific nuclear proteins interact with the rous sarcoma virus internal enhancer and share a common element with the enhancer located in the long terminal repeat of the virus",
abstract = "We have documented that the Rous sarcoma virus (RSV) internal enhancer functions in the nontransformed Baby Hamster Kidney (BHK) cell line. The sequences within this region were assayed for their ability to bind to specific factors present in BHK nuclear extracts using the gel retardation assay and DNAse I footprinting. At least two sequences within the internal enhancer which can specifically bind nuclear factors in vitro have been identified. These regions are located between nucleotides 813-850 and 856-877. These sites map within the overall region of the internal enhancer which has been shown to be essential for enhancer activity and within the specific region which can function as an orientation independent enhancer. Using the DNase I footprinting and binding data to design an oligonucleotide, we have demonstrated that an oligonucleotide extending from nucleotides 804-877 will substitute efficiently as an enhancer. We also demonstrate that the SV40 enhancer does not compete for the factors which bind to the RSV internal enhancer, whereas an oligonucleotide to the binding site for EFII in the LTR can compete for factor binding to the internal enhancer.",
author = "Karnitz, {Larry M} and Steven Faber and Roger Chalkley",
year = "1987",
month = "12",
day = "10",
doi = "10.1093/nar/15.23.9841",
language = "English (US)",
volume = "15",
pages = "9841--9859",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Specific nuclear proteins interact with the rous sarcoma virus internal enhancer and share a common element with the enhancer located in the long terminal repeat of the virus

AU - Karnitz, Larry M

AU - Faber, Steven

AU - Chalkley, Roger

PY - 1987/12/10

Y1 - 1987/12/10

N2 - We have documented that the Rous sarcoma virus (RSV) internal enhancer functions in the nontransformed Baby Hamster Kidney (BHK) cell line. The sequences within this region were assayed for their ability to bind to specific factors present in BHK nuclear extracts using the gel retardation assay and DNAse I footprinting. At least two sequences within the internal enhancer which can specifically bind nuclear factors in vitro have been identified. These regions are located between nucleotides 813-850 and 856-877. These sites map within the overall region of the internal enhancer which has been shown to be essential for enhancer activity and within the specific region which can function as an orientation independent enhancer. Using the DNase I footprinting and binding data to design an oligonucleotide, we have demonstrated that an oligonucleotide extending from nucleotides 804-877 will substitute efficiently as an enhancer. We also demonstrate that the SV40 enhancer does not compete for the factors which bind to the RSV internal enhancer, whereas an oligonucleotide to the binding site for EFII in the LTR can compete for factor binding to the internal enhancer.

AB - We have documented that the Rous sarcoma virus (RSV) internal enhancer functions in the nontransformed Baby Hamster Kidney (BHK) cell line. The sequences within this region were assayed for their ability to bind to specific factors present in BHK nuclear extracts using the gel retardation assay and DNAse I footprinting. At least two sequences within the internal enhancer which can specifically bind nuclear factors in vitro have been identified. These regions are located between nucleotides 813-850 and 856-877. These sites map within the overall region of the internal enhancer which has been shown to be essential for enhancer activity and within the specific region which can function as an orientation independent enhancer. Using the DNase I footprinting and binding data to design an oligonucleotide, we have demonstrated that an oligonucleotide extending from nucleotides 804-877 will substitute efficiently as an enhancer. We also demonstrate that the SV40 enhancer does not compete for the factors which bind to the RSV internal enhancer, whereas an oligonucleotide to the binding site for EFII in the LTR can compete for factor binding to the internal enhancer.

UR - http://www.scopus.com/inward/record.url?scp=0023650424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023650424&partnerID=8YFLogxK

U2 - 10.1093/nar/15.23.9841

DO - 10.1093/nar/15.23.9841

M3 - Article

VL - 15

SP - 9841

EP - 9859

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 23

ER -